-
November 7, 2024 Lupin Q2 FY2025 Results
-
October 28, 2024 Lupin to focus on the development of inhalers with near-zero global warming potential propellants
-
October 21, 2024 Lupin Appoints Claus Jepsen as President, Global Specialty
-
October 15, 2024 Lupin Launches First Generic of Pred Forte® in the United States
-
October 14, 2024 Lupin Launches Aptivate Achi Bhookh Fest in Mumbai and Suburbs
-
October 4, 2024 Lupin Acquires Nine Brands of Medical Nutritional Institute in South Africa
-
September 30, 2024 Lupin and Scope Sign a Distribution Agreement for the Commercialization of Optase® Range of Products in Mexico
-
September 27, 2024 Lupin Signs Distribution Agreement with Celnova for Orphan Drug NaMuscla®
-
September 18, 2024 Lupin Receives Approval from U.S. FDA for Bumetanide Injection, USP
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications